My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Opening of Bids - 2025 Curb and Sidewalk Program Proj No 125-001 - Premium Services
sbend
>
Public
>
Public Works
>
Board of Works Documents
>
2025
>
Opening of Bids
>
Opening of Bids - 2025 Curb and Sidewalk Program Proj No 125-001 - Premium Services
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/27/2025 2:12:43 PM
Creation date
5/27/2025 2:11:01 PM
Metadata
Fields
Template:
Board of Public Works
Document Type
Projects
Document Date
5/27/2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
111
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
Required DOT Drug Tests & Cutoffs <br />TYPE OF DRUG <br />INITIAL TEST <br />CONFIRMATORY TEST <br />CONFIRMATORY TEST <br />Initial Test Analyte <br />Cutoff Concentration" <br />Analyte <br />Cutoff Concentration <br />Marijuana metabolites (THCA 10 <br />50 n /mL11 <br />THCA <br />15 nghTil- <br />Cocaine metabolite <br />150 ng/mLl1 <br />Benzoylecgonine <br />100 ng/mL <br />Benzo lec onine <br />Opioids: <br />Codeine/Morphine <br />2000 ng/mL <br />Codeine <br />2000 ng/mL <br />Morphine <br />2000 ng/mL <br />Hydrocodone/Hydromorphone <br />300 nghnL <br />Hydrocodone <br />100 ng/mL <br />Hydromorphone <br />100 ng/mL <br />Oxycodone/Oxymorphone <br />100 ng/mL <br />Oxycodone <br />100 ng/mL <br />Oxymorphone <br />100 ng/mL <br />6-AceE Imor tine <br />10 n /mL <br />6-Acet Imor hive - <br />10 n /mL <br />Phonc clidine <br />25 n /ml- <br />Phencyclidine <br />25 n /mL <br />Amphetamine/Methamphetamine <br />500 ng/mL <br />Amphetamine - <br />250 ng/mL <br />Methamphetamine <br />250 nglml- <br />MDMAI2/MDA" <br />500 ng/mL <br />MDMA <br />250 ng/mL <br />MDA <br />250 n hnL _ <br />Table 1 <br />s Fm'grouped analytes (i.e„ two m' mdre analytes that are in the same drug class and have the same initial test cutoff): <br />Inuntntoassdy: The test must be calibrated with one analyte from the group identified as the target analyte. The cross -reactivity <br />of the immunoassay to the other analyte(s) within the group must be 80 percent or greater. If not, separate immunoassays must be <br />used for the analytes within the group. <br />Alternate technology: Either one analyte or all analytes fi'om the group must be used for calibration, depending on the <br />technology. At least one analyte within the group must have a concentration equal to or greater than the initial test cutoff or, <br />alternatively, the sum of the analytes present (i.e„ equal to or greater than the laboratory's validated limit of quantification) must <br />be equal to or greater than the initial test cutoff, <br />to An invnunoassay must be calibrated with the target analyte Delta-9-tetrahydrocannabinol-9-carboxylic acid (THCA) <br />I Alternate technology (VICA and benzoyleegonine): When using alternate technology to test for THCA and Benzoylecgonine, <br />the screening and confirmatory test cutoff concentrations must be the same respectively (i.e., 15 ng/mL for THCA and 100 ug/mL <br />for Benzoylecgnine). <br />Iz Me(hylenedioxyn)ethamphetamine (MDMA) <br />11 Methylenedioxyamphetamine (MDA) <br />Premium Concrete Services, Inc.- PIiMSA DRUG/ALCOHOL PLAN 25 <br />C� IJATIONAL COMPLIANCE MADIAOEME�IT 6ERVICti, INC. (NCMIS) 2011 (,i�,lalo L02 n. Tl�e nIC1A5 rlen la <br />the sub�ecl of n reyleteleU copyrlyht a�i<I Is riotecletl Uy copynglil lu,vs in Ilse U S. ailU elsewhxre. Alt riglils <br />esenetl. <br />
The URL can be used to link to this page
Your browser does not support the video tag.